BLFS · As filed with the SEC

Biolife Solutions cash flow statement, by quarter

The statement as Biolife Solutions presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Unaudited Condensed Consolidated Statements of Cash Flows · USD thousands

USD thousands	Q2 2026^† 3 months ended Jun 30, 2026	Q1 2026 3 months ended Mar 31, 2026	Q4 2025^† 3 months ended Dec 31, 2025	Q3 2025^† 3 months ended Sep 30, 2025	Q2 2025^† 3 months ended Jun 30, 2025	Q1 2025 3 months ended Mar 31, 2025	Q4 2024^† 3 months ended Dec 31, 2024	Q3 2024^† 3 months ended Sep 30, 2024
Cash flows from operating activities
Net income (loss)	45,104^†	1,186	11,070^†	621^†	(15,838)^†	(448)	12,459^†	(1,703)^†
Adjustments to reconcile net loss to net cash used in operating activities
Impairment of intangible assets	—	—	—	—	—	—	0^†	—
Impairment of long-lived assets	—	—	—	—	—	—	0^†	—
Settlement of Global Cooling escrow	—	—	—	—	—	—	—	0^†
Depreciation	411^†	374	261^†	636^†	674^†	682	937^†	1,407^†
Amortization of intangible assets	398^†	325	325^†	699^†	708^†	702	767^†	910^†
Amortization of loan costs	—	—	—	—	—	—	0^†	0^†
Stock-based compensation	3,854^†	4,806	7,077^†	5,904^†	5,859^†	4,153	10,692^†	5,329^†
Non-cash lease expense	1,849^†	(188)	—	1,323^†	358^†	312	—	404^†
Deferred income tax (benefit) expense	(42,431)^†	9	0^†	14^†	45^†	6	24^†	(93)^†
Change in fair value of contingent consideration	—	—	—	—	—	—	0^†	0^†
Change in fair value of equity investment and other	—	—	(942)^†	(41)^†	—	—	0^†	0^†
Accretion of available-for-sale investments	(75)^†	(122)	(201)^†	(230)^†	(200)^†	(105)	(67)^†	(89)^†
Gain on disposal of assets held for rent, net	0^†	0	0^†	167^†	156^†	187	109^†	123^†
Loss on disposal of property and equipment, net	—	—	11^†	0^†	0^†	0	216^†	4^†
IPR&D expense	—	—	0^†	0^†	—	—	0^†	0^†
Loss on disposal of Global Cooling	—	—	—	0^†	—	—	—	0^†
Change in operating assets and liabilities
Accounts receivable, trade, net	2,405^†	(5,104)	1,938^†	(782)^†	(893)^†	1	(1,233)^†	208^†
Inventories	(2,757)^†	(2,679)	(2,331)^†	(197)^†	(187)^†	1,447	(1,343)^†	317^†
Prepaid expenses and other assets	(246)^†	3,218	(462)^†	(3,000)^†	242^†	181	(3,921)^†	(1,406)^†
Accounts payable	(1,370)^†	2,206	(952)^†	(679)^†	373^†	(828)	1,165^†	(373)^†
Accrued expenses and other current liabilities	(755)^†	(4,400)	680^†	1,564^†	864^†	(4,252)	7,059^†	744^†
Sales taxes payable	(39)^†	(148)	(1,385)^†	105^†	(298)^†	(327)	(84)^†	(501)^†
Warranty liability	—	—	—	—	—	—	(50)^†	4^†
Other	0^†	26	264^†	0^†	(16)^†	16	8^†	(1)^†
Net cash provided by operating activities	6,348^†	(491)	4,916^†	6,104^†	7,368^†	1,727	1,645^†	4,802^†
Cash flows from investing activities
Purchases of available-for-sale securities	(14,925)^†	(20,430)	(36,670)^†	(13,090)^†	(33,979)^†	(30,324)	(2,401)^†	(5,302)^†
Proceeds from sale of available-for-sale securities	2,359^†	2,331	3,238^†	1,836^†	1,182^†	573	909^†	819^†
Maturities of available-for-sale securities	12,150^†	16,436	15,412^†	10,962^†	5,390^†	3,000	2,800^†	4,350^†
Purchases of assets held for rent	0^†	0	(101)^†	(373)^†	(162)^†	(250)	(40)^†	(434)^†
Purchases of property and equipment	—	—	—	(3,302)^†	(1,743)^†	(175)	—	(1,114)^†
Purchases of property and equipment	(1,043)^†	(167)	—	—	(1,743)^†	—	—	—
Investment in IPR&D	—	—	0^†	0^†	—	—	0^†	0^†
Investment in convertible promissory note	—	—	0^†	—	—	—	0^†	—
Payments on divestiture of Global Cooling	—	—	0^†	0^†	—	—	0^†	0^†
Net cash used in investing activities	(1,579)^†	(1,830)	1,137^†	(5,967)^†	(39,533)^†	(27,176)	73,637^†	(1,681)^†
Cash flows from financing activities
Proceeds from exercises of common stock options	3^†	190	0^†	0^†	18^†	—	65^†	46^†
Proceeds from financed insurance premium	—	—	0^†	—	—	—	0^†	—
Payments on term loans	(2,500)^†	(2,500)	(2,500)^†	(2,500)^†	(2,500)^†	(2,500)	(2,500)^†	(2,500)^†
Payments on equipment loans	—	—	0^†	0^†	0^†	0	(926)^†	(214)^†
Payment of tax withholding on vesting of shares	(1,097)^†	(5,588)	—	—	0^†	—	—	—
Payments on financed insurance premium	0^†	0	0^†	(67)^†	(406)^†	(502)	(667)^†	(483)^†
Other	0^†	3	4^†	9^†	10^†	10	(58)^†	16^†
Net cash used in financing activities	(3,594)^†	(7,895)	(2,496)^†	(2,558)^†	(2,878)^†	(2,992)	(4,086)^†	(1,041)^†
Net decrease in cash and cash equivalents	1,175^†	(10,216)	3,557^†	(2,421)^†	(35,043)^†	(28,441)	71,196^†	2,080^†
Cash and cash equivalents – beginning of period	—	—	29,481	31,902	66,945	95,386	24,161	22,045
Cash and cash equivalents – beginning of period	22,822	33,038	—	31,902	66,945	95,386	—	—
Effects of currency translation on cash and cash equivalents	—	—	0^†	0^†	0^†	0	29^†	36^†
Cash and cash equivalents – end of period	—	—	—	29,481	31,902	66,945	—	24,161
Cash and cash equivalents – end of period	23,997	22,822	33,038	—	31,902	—	95,386	—
Non-cash investing and financing activities
Purchase of property and equipment not yet paid	102^†	58	(450)^†	360^†	(462)^†	552	10^†	(205)^†
Assets acquired under operating leases	—	—	0^†	0^†	—	—	531^†	4,993^†
Assets acquired under finance leases	—	—	—	—	—	—	0^†	—
Unrealized gains (losses) on available-for-sale securities	(91)^†	(252)	2^†	59^†	56^†	(9)	28^†	(64)^†
Unrealized gain on currency translation	—	—	0^†	0^†	0^†	0	(3)^†	(1)^†
Non-cash acquisition of PanTHERA	—	—	0^†	0^†	—	—	0^†	0^†
Returned shares from settlement of Global Cooling escrow	—	—	—	—	—	—	0^†	—
Cash interest paid	30^†	73	118^†	164^†	215^†	265	372^†	407^†

† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.